Channeling Hope Foundation

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Aprepitant for the Treatment of CLIFAHDD	Channelopathies, Disease Attributes, Dyskinesias, Facies, Muscle Hypotonia, Neurobehavioral Manifestations, Neurologic Manifestations, Neuromuscular Manifestations, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, atactic disorder, non-human animal, communication disorder, congenital contractures of the limbs and face, hypotonia, and developmental delay, disease, learning disability, nervous system disorder, neurodevelopmental disorder, psychiatric disorder	Recruiting	Early phase 1	2026-10-05		NCT07845825

Clinical trials